Analyst ratings and price targets often influence the stock price. In this case, two major financial institutions, Truist Securities and Barclays, have raised their price targets for Amneal Pharmaceuticals, indicating their positive outlook on the stock. This is likely to boost investor confidence and drive up the stock price in the short term.